{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T22:34:32Z","timestamp":1783118072323,"version":"3.54.6"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109823","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:46:37Z","timestamp":1775180797000},"page":"109823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of a potent and orally available SOS1 inhibitor with antitumor efficacy in KRAS-mutant colorectal cancers"],"prefix":"10.1016","volume":"175","author":[{"given":"Xingchen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinglan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109823_bb0005","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znad241.274","article-title":"ThTP4.2 complications following emergency colorectal cancer resections: a single Centre cohort study","volume":"110","author":"Gok","year":"2023","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.bioorg.2026.109823_bb0010","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1200\/JCO.2019.37.4_suppl.510","article-title":"Early detection of lower GI tract tumors by dedicated assessment of the colon on routine computed tomography (CT) imaging: an observational study","volume":"37","author":"Chang","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.109823_bb0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1200\/JCO.2019.37.4_suppl.523","article-title":"Prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer patients: a systematic literature review and meta-analysis","volume":"37","author":"Lowe","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.109823_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102699","article-title":"Discovery of decreased ferroptosis in male colorectal cancer patients with KRAS mutations","volume":"62","author":"Yan","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioorg.2026.109823_bb0025","doi-asserted-by":"crossref","first-page":"e14147","DOI":"10.1200\/jco.2012.30.15_suppl.e14147","article-title":"Prevalence of low-penetrance KRAS (codons 12\/13 and 61) and BRAF mutations in metastatic colorectal carcinoma","volume":"30","author":"Rojo","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.109823_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111717","article-title":"The current understanding on the impact of KRAS on colorectal cancer","volume":"140","author":"Meng","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.109823_bb0035","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1186\/s12885-022-10235-w","article-title":"Prevalence and patterns of mutations in RAS\/RAF\/MEK\/ERK\/MAPK signaling pathway in colorectal cancer in north africa","volume":"22","author":"Jafari","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bioorg.2026.109823_bb0040","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev-med-080819-033145","article-title":"Therapeutics targeting mutant KRAS","volume":"72","author":"Thein","year":"2021","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bioorg.2026.109823_bb0045","doi-asserted-by":"crossref","first-page":"e15090","DOI":"10.1200\/JCO.2019.37.15_suppl.e15090","article-title":"The prognostic value of KRAS mutation in locally advanced rectal cancer","volume":"37","author":"Bakalov","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.109823_bb0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41575-023-00772-5","article-title":"Mutations linked to chemotherapy resistance in colorectal cancer","volume":"20","author":"Fyfe","year":"2023","journal-title":"Nat. Rev. Gas. Tro. Hepat."},{"key":"10.1016\/j.bioorg.2026.109823_bb0055","first-page":"1757","article-title":"A pan-KRAS inhibitor impedes common KRAS oncoproteins and tumor growth, cancer","volume":"13","year":"2023","journal-title":"Discov"},{"key":"10.1016\/j.bioorg.2026.109823_bb0060","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1073\/pnas.1413185112","article-title":"Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices","volume":"112","author":"Leshchiner","year":"2015","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.109823_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.crstbi.2023.100115","article-title":"Studying early structural changes in SOS1 mediated KRAS activation mechanism","volume":"7","author":"Bhadhadhara","year":"2024","journal-title":"Curr. Res. Struct. Biol."},{"key":"10.1016\/j.bioorg.2026.109823_bb0070","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s10495-025-02154-5","article-title":"FOXP2\/SOS1\/AKT negative feedback loop inhibits cell proliferation in KRAS-mutant colorectal cancer","volume":"30","author":"Liu","year":"2025","journal-title":"Apoptosis"},{"key":"10.1016\/j.bioorg.2026.109823_bb0075","doi-asserted-by":"crossref","first-page":"2202448","DOI":"10.1002\/advs.202202448","article-title":"PPDPF promotes the development of mutant KRAS-driven pancreatic ductal adenocarcinoma by regulating the GEF activity of SOS1","volume":"10","author":"Ni","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioorg.2026.109823_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cbpa.2021.02.014","article-title":"Targeting son of sevenless 1: the pacemaker of KRAS","volume":"62","author":"Kessler","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.bioorg.2026.109823_bb0085","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1021\/acs.jmedchem.2c01729","article-title":"Development of son of sevenless homologue 1 (SOS1) modulators to treat cancers by regulating RAS signaling","volume":"66","author":"Luo","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109823_bb0090","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/1535-7163.MCT-23-0870","article-title":"The SOS1 inhibitor MRTX0902 blocks KRAS activation and demonstrates antitumor activity in cancers dependent on KRAS nucleotide loading","volume":"23","author":"Sudhakar","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2026.109823_bb0095","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1158\/1538-7445.AM2025-4373","article-title":"Abstract 4373: discovery and characterization of BAY 3498264: a small molecule inhibitor targeting the RAS-SOS1 interaction","volume":"85","author":"Guthof","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109823_bb0100","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1021\/acs.jmedchem.2c00741","article-title":"Design and discovery of MRTX0902, a potent, selective, brain-penetrant, and orally bioavailable inhibitor of the SOS1: KRAS protein-protein interaction","volume":"65","author":"Ketcham","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109823_bb0105","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1080\/13543776.2021.1952984","article-title":"Small molecule son of sevenless 1 (SOS1) inhibitors: a review of the patent literature","volume":"31","author":"Thompson","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2026.109823_bb0110","first-page":"1294","volume":"5","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.bioorg.2026.109823_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101230","article-title":"Cytotoxicity of combinations of the pan-KRAS inhibitor BAY-293 against primary non-small lung cancer cells","volume":"14","author":"Plangger","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.bioorg.2026.109823_bb0120","doi-asserted-by":"crossref","first-page":"16432","DOI":"10.1021\/acs.jmedchem.2c01300","article-title":"Development of SOS1 inhibitor-based degraders to target KRAS-mutant colorectal cancer","volume":"65","author":"Bian","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109823_bb0125","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS3651","article-title":"A phase i, open-label, dose-escalation trial of BI 1701963 as monotherapy and in combination with trametinib in patients with KRAS mutated advanced or metastatic solid tumors","volume":"38","author":"Gort","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.109823_bb0130","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1158\/1538-7445.AM2020-1091","article-title":"Abstract 1091: BI-3406 and BI 1701963: potent and selective SOS1:\u202f: KRAS inhibitors induce regressions in combination with MEK inhibitors or irinotecan","volume":"80","author":"Gerlach","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109823_bb0135","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2021-CT210","article-title":"Abstract CT210: trial in process: phase 1 studies of BI 1701963, a SOS1:\u202f: KRAS inhibitor, in combination with MEK inhibitors, irreversible KRASG12C inhibitors or irinotecan","volume":"81","author":"Hofmann","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109823_bb0140","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1158\/1538-7445.AM2022-2667","volume":"82","author":"Waizenegger","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109823_bb0145","first-page":"953","article-title":"Phase i dose-escalation trial of BI 1701963 with or without BI 3011441 in patients with KRAS-mutated solid tumors","volume":"113","author":"Chia","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bioorg.2026.109823_bb0150","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2022-ND02","article-title":"Abstract ND02: MRTX0902: a SOS1 inhibitor for therapeutic intervention of KRAS-driven cancers","volume":"82","author":"Ketcham","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109823_bb0155","article-title":"In situ inhibitor synthesis and screening by fluorescence polarization: an efficient approach for accelerating drug discovery","volume":"61","author":"Li","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2026.109823_bb0160","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1039\/D4OB02021A","article-title":"Fluorescence polarization assays to study carbohydrate-protein interactions","volume":"23","author":"de Paz","year":"2025","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2026.109823_bb0165","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nprot.2008.15","article-title":"Displacement of protein-bound aptamers with small molecules screened by fluorescence polarization","volume":"3","author":"Hafner","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2026.109823_bb0170","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1517\/17460441.2011.537322","article-title":"Fluorescence polarization assays in small molecule screening","volume":"6","author":"Lea","year":"2011","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.bioorg.2026.109823_bb0175","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.1021\/acs.jmedchem.8b01108","article-title":"Discovery and structure-based optimization of Benzimidazole-derived activators of SOS1-mediated nucleotide exchange on RAS","volume":"61","author":"Hodges","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109823_bb0180","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1021\/acs.jmedchem.9b01035","article-title":"Development and characterization of a fluorescent probe for GLS1 and the application for high-throughput screening of allosteric inhibitors","volume":"62","author":"Xu","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109823_bb0185","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1021\/acs.jmedchem.3c00881","article-title":"Design of tracers in fluorescence polarization assay for extensive application in small molecule drug discovery","volume":"66","author":"Hua","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109823_bb0190","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1158\/2159-8290.CD-20-0142","article-title":"BI-3406, a potent and selective SOS1-KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition","volume":"11","author":"Hofmann","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.109823_bb0195","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1021\/acs.jmedchem.4c00058","article-title":"Discovery of ROR\u03b3 allosteric fluorescent probes and their application: fluorescence polarization, screening, and bioimaging","volume":"67","author":"Yu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109823_bb0200","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1038\/s41467-022-32612-6","article-title":"Rational design of a sensitivity-enhanced tracer for discovering efficient APC-Asef inhibitors","volume":"13","author":"Zhong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109823_bb0205","doi-asserted-by":"crossref","first-page":"20290","DOI":"10.1002\/anie.202007673","article-title":"Dual-functionalisation of fluorophores for the preparation of targeted and selective probes","volume":"59","author":"Trinh","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2026.109823_bb0210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s42004-022-00691-7","article-title":"Controlling oncogenic KRAS signaling pathways with a palladium-responsive peptide","volume":"5","author":"Learte-Aymam\u00ed","year":"2022","journal-title":"Communications Chemistry"},{"key":"10.1016\/j.bioorg.2026.109823_bb0215","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1073\/pnas.1812963116","article-title":"Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction","volume":"116","author":"Hillig","year":"2019","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.109823_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202219095","article-title":"Nanobody loop mimetics enhance son of sevenless 1-catalyzed nucleotide exchange on RAS","volume":"62","author":"Van holsbeeck","year":"2023","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2026.109823_bb0225","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1073\/pnas.1812963116","article-title":"Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interaction","volume":"116","author":"Hillig","year":"2019","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.bioorg.2026.109823_bb0230","doi-asserted-by":"crossref","first-page":"15856","DOI":"10.1021\/acs.jmedchem.2c01517","article-title":"Design and structural optimization of orally bioavailable SOS1 inhibitors for the treatment of KRAS-driven carcinoma","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109823_bb0235","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/acsmedchemlett.5c00302","article-title":"Focused structure-based virtual screening identifies novel inhibitors of SOS1","volume":"16","author":"Bonomo","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109823_bb0240","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/acsmedchemlett.4c00156","article-title":"Lead identification of novel naphthyridine derivatives as potent SOS1 inhibitors","volume":"15","author":"Li","year":"2024","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109823_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.117065","article-title":"Novel potent SOS1 inhibitors containing a tricyclic quinazoline scaffold: a joint view of experiments and simulations","volume":"282","author":"Qing","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109823_bb0250","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.3390\/cancers13225599","article-title":"Oncogenic KRAS: signaling and drug resistance","volume":"13","author":"Kim","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2026.109823_bb0255","doi-asserted-by":"crossref","first-page":"eaar8371","DOI":"10.1126\/scisignal.aar8371","article-title":"Oncogenic RAS isoforms show a hierarchical requirement for the guanine nucleotide exchange factor SOS2 to mediate cell transformation","volume":"11","author":"Sheffels","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bioorg.2026.109823_bb0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1158\/2159-8290.CD-20-1331","article-title":"Suppressing nucleotide exchange to inhibit KRAS-mutant tumors","volume":"11","author":"Zhao","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bioorg.2026.109823_bb0265","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2025-LB429","article-title":"Abstract LB429: discovery of a novel SOS1-KRASmulti inhibitor, HM101207, demonstrates a broad-spectrum antitumor activity across KRAS-MAPK mutant cancers","volume":"85","author":"Choi","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2026.109823_bb0270","doi-asserted-by":"crossref","first-page":"13158","DOI":"10.1021\/acs.jmedchem.2c00986","article-title":"Discovery of orally bioavailable SOS1 inhibitors for suppressing KRAS-driven carcinoma","volume":"65","author":"He","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109823_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130282","article-title":"Design and structural optimization of novel SOS1 inhibitors in KRAS-driven cancers","volume":"125-126","author":"Chen","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826003597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:34:27Z","timestamp":1776134067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826003597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":55,"alternative-id":["S0045206826003597"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109823","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a potent and orally available SOS1 inhibitor with antitumor efficacy in KRAS-mutant colorectal cancers","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109823"}}